These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27294364)

  • 21. Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes.
    Ma E; Harrington LB; O'Connell MR; Zhou K; Doudna JA
    Mol Cell; 2015 Nov; 60(3):398-407. PubMed ID: 26545076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standards for plant synthetic biology: a common syntax for exchange of DNA parts.
    Patron NJ; Orzaez D; Marillonnet S; Warzecha H; Matthewman C; Youles M; Raitskin O; Leveau A; Farré G; Rogers C; Smith A; Hibberd J; Webb AA; Locke J; Schornack S; Ajioka J; Baulcombe DC; Zipfel C; Kamoun S; Jones JD; Kuhn H; Robatzek S; Van Esse HP; Sanders D; Oldroyd G; Martin C; Field R; O'Connor S; Fox S; Wulff B; Miller B; Breakspear A; Radhakrishnan G; Delaux PM; Loqué D; Granell A; Tissier A; Shih P; Brutnell TP; Quick WP; Rischer H; Fraser PD; Aharoni A; Raines C; South PF; Ané JM; Hamberger BR; Langdale J; Stougaard J; Bouwmeester H; Udvardi M; Murray JA; Ntoukakis V; Schäfer P; Denby K; Edwards KJ; Osbourn A; Haseloff J
    New Phytol; 2015 Oct; 208(1):13-9. PubMed ID: 26171760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [CRISPR/Cas system for genome editing in pluripotent stem cells].
    Vasil'eva EA; Melino D; Barlev NA
    Tsitologiia; 2015; 57(1):19-30. PubMed ID: 25872372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR Immunological Memory Requires a Host Factor for Specificity.
    Nuñez JK; Bai L; Harrington LB; Hinder TL; Doudna JA
    Mol Cell; 2016 Jun; 62(6):824-833. PubMed ID: 27211867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cpf1 shape-shifts for streamlined CRISPR cleavage.
    White MF
    Nat Struct Mol Biol; 2016 May; 23(5):365-6. PubMed ID: 27142322
    [No Abstract]   [Full Text] [Related]  

  • 26. Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair.
    Gutschner T; Haemmerle M; Genovese G; Draetta GF; Chin L
    Cell Rep; 2016 Feb; 14(6):1555-1566. PubMed ID: 26854237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual nuclease activity of a Cas2 protein in CRISPR-Cas subtype I-B of Leptospira interrogans.
    Dixit B; Ghosh KK; Fernandes G; Kumar P; Gogoi P; Kumar M
    FEBS Lett; 2016 Apr; 590(7):1002-16. PubMed ID: 26950513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Anti-CRISPR Story: A Battle for Survival.
    Maxwell KL
    Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusion of SpCas9 to E. coli Rec A protein enhances CRISPR-Cas9 mediated gene knockout in mammalian cells.
    Lin L; Petersen TS; Jensen KT; Bolund L; Kühn R; Luo Y
    J Biotechnol; 2017 Apr; 247():42-49. PubMed ID: 28259533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylase-assisted subcloning for high throughput BioBrick assembly.
    Matsumura I
    PeerJ; 2020; 8():e9841. PubMed ID: 32974095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ISC, a Novel Group of Bacterial and Archaeal DNA Transposons That Encode Cas9 Homologs.
    Kapitonov VV; Makarova KS; Koonin EV
    J Bacteriol; 2015 Dec; 198(5):797-807. PubMed ID: 26712934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR-cas loci profiling of Cronobacter sakazakii pathovars.
    Ogrodzki P; Forsythe SJ
    Future Microbiol; 2016 Dec; 11():1507-1519. PubMed ID: 27831749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Golden Gate assembly of BioBrick-compliant parts using Type II restriction endonucleases.
    Matsumura I
    Biotechniques; 2022 May; 72(5):185-193. PubMed ID: 35255734
    [No Abstract]   [Full Text] [Related]  

  • 34. Meet the Editors.
    Cell; 2016 Jun; 165(6):1295-1297. PubMed ID: 27259138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determining the specificities of TALENs, Cas9, and other genome-editing enzymes.
    Pattanayak V; Guilinger JP; Liu DR
    Methods Enzymol; 2014; 546():47-78. PubMed ID: 25398335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered Cpf1 variants with altered PAM specificities.
    Gao L; Cox DBT; Yan WX; Manteiga JC; Schneider MW; Yamano T; Nishimasu H; Nureki O; Crosetto N; Zhang F
    Nat Biotechnol; 2017 Aug; 35(8):789-792. PubMed ID: 28581492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
    Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
    Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SEVA Linkers: A Versatile and Automatable DNA Backbone Exchange Standard for Synthetic Biology.
    Kim SH; Cavaleiro AM; Rennig M; Nørholm MH
    ACS Synth Biol; 2016 Oct; 5(10):1177-1181. PubMed ID: 26917044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SnapShot: Class 2 CRISPR-Cas Systems.
    Makarova KS; Zhang F; Koonin EV
    Cell; 2017 Jan; 168(1-2):328-328.e1. PubMed ID: 28086097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.